Articles

Podcasts

Videos

Geriatrics

Geriatric medicine condition center page is a comprehensive resource for clinical news and insights on frequent geriatric-related diseases and conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for sleep disorder, dementia, Alzheimer's disease, and more.

Data show 15-mg edoxaban dose was superior to placebo in preventing stroke or systemic embolism in all 3 age strata studied, with higher incidence of major bleeding. 

Low-Dose Edoxaban Reduces Stroke incidence in Older Patients with Atrial Fibrillation 

After adjustment for age and sex, data show the reduction in mortality rates in the patients receiving dialysis was greater than the general population. 

Mortality Rates From CV Cause of Death Saw Improvement with Dialysis 

Greater increases were observed among members of racial and ethnic minority groups, with the highest increase among non-Hispanic Black individuals. 

Increase in Heart Disease, Stroke Risk-Associated Death Observed From 2019 - 2020 

Data show the absolute risk reductions of treatment with statins in terms of all-cause mortality, myocardial infarction, and stroke are modest compared with the relative risk reductions. 

Absolute Benefits of Statins Cautioned Due To Significant Heterogeneity 

A positive CDI test was more common in patients with suffered an aneurysmal subarachnoid hemorrhage than it was in patients with intracerebral hemorrhage or ischemic stroke.

C Difficile Infection Rates Low in Stroke Patients

Bentracimab achieved the predetermined primary endpoint of immediate and sustained reversal of the antiplatelet effects of ticagrelor in the REVERSE-IT trial.

Deepak Bhatt, MD, MPH: The Potential of Bentracimab

Treatment with statins, nitrates, dihydropyridines, verapamil, and proton-pump inhibitors were predictors of death or ischemic events for patients in the HGFR group.

Investigators Identify Predictors or Poor Outcomes for Patients with Stable Coronary Artery Disease

Data show SGLT2 inhibitor therapy, in comparison to GLP-1 RA therapy, was associated with slightly lower risk for myocardial infarction (MI) or stroke in patients with CVD. 

Use of SGLT2i Show Greater Risk Reduction in Patients with Type 2 Diabetes, CVD

In his presentation at TMIOA, Dr. Inzucchi referenced several diabetes medications and glucose management methods that resulted in a reduction of stroke risk in patients.










Silvio Inzucchi, MD: New Methods in Stroke Prevention and Cardiovascular Events

The vagus nerve stimulation system is the first of its kind stroke rehabilitation system, after supporting data from the VNS-REHAB trial suggested its efficacy in improving FMA-UE scores. 

FDA Approves VNS System for Ischemic Stroke Motor Deficits 

On the HCPLive stroke page, resources on the topics of medical news and expert insight into CVA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on stroke medicine, and more.